A Phase 1b, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Safety and Efficacy of Oral Zavegepant in Subjects With Mild Allergic Asthma

A study to learn about the effect and safety of oral zavegepant in participants with mild allergic asthma

Category & Conditions: Respiratory Disease

Medicine: ZAVZPRET™(ZAVEGEPANT)

ClinicalTrials.gov Identifier (NCT): NCT04987944

Protocol ID: C5301005

Print Download

Open Plain Language Summary Result: Click here